questionsmedicales.fr
Technologie, industrie et agriculture
Produits manufacturés
Dispositifs pour fumer
Produits du tabac
Produits du tabac : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Produits du tabac : Questions médicales les plus fréquentes",
"headline": "Produits du tabac : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Produits du tabac : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-18",
"dateModified": "2025-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Produits du tabac"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Dispositifs pour fumer",
"url": "https://questionsmedicales.fr/mesh/D000074602",
"about": {
"@type": "MedicalCondition",
"name": "Dispositifs pour fumer",
"code": {
"@type": "MedicalCode",
"code": "D000074602",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Tabac sans fumée",
"alternateName": "Tobacco, Smokeless",
"url": "https://questionsmedicales.fr/mesh/D014030",
"about": {
"@type": "MedicalCondition",
"name": "Tabac sans fumée",
"code": {
"@type": "MedicalCode",
"code": "D014030",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Tabac pour pipe à eau",
"alternateName": "Tobacco, Waterpipe",
"url": "https://questionsmedicales.fr/mesh/D000073846",
"about": {
"@type": "MedicalCondition",
"name": "Tabac pour pipe à eau",
"code": {
"@type": "MedicalCode",
"code": "D000073846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "J01.637.767.844.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Produits du tabac",
"alternateName": "Tobacco Products",
"code": {
"@type": "MedicalCode",
"code": "D062789",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Takahiro Tabuchi",
"url": "https://questionsmedicales.fr/author/Takahiro%20Tabuchi",
"affiliation": {
"@type": "Organization",
"name": "Cancer Control Center, Osaka International Cancer Institute, 3-1-69 Otemae Chuo-ku, Osaka, Japan."
}
},
{
"@type": "Person",
"name": "Jennifer B Unger",
"url": "https://questionsmedicales.fr/author/Jennifer%20B%20Unger",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America."
}
},
{
"@type": "Person",
"name": "Pamela M Ling",
"url": "https://questionsmedicales.fr/author/Pamela%20M%20Ling",
"affiliation": {
"@type": "Organization",
"name": "Center for Tobacco Control Research and Education, University of California, San Francisco, San Francisco, California."
}
},
{
"@type": "Person",
"name": "Silvano Gallus",
"url": "https://questionsmedicales.fr/author/Silvano%20Gallus",
"affiliation": {
"@type": "Organization",
"name": "Department of Environmental Health Sciences, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, 20156 Milan, Italy."
}
},
{
"@type": "Person",
"name": "Jessica L Barrington-Trimis",
"url": "https://questionsmedicales.fr/author/Jessica%20L%20Barrington-Trimis",
"affiliation": {
"@type": "Organization",
"name": "Department of Preventive Medicine, Keck School of Medicine, University of Southern California, United States of America. Electronic address: jtrimis@usc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Kinetin induces microtubular breakdown, cell cycle arrest and programmed cell death in tobacco BY-2 cells.",
"datePublished": "2022-10-14",
"url": "https://questionsmedicales.fr/article/36239807",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00709-022-01814-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "ITF2357 induces cell cycle arrest and apoptosis of meningioma cells via the PI3K-Akt pathway.",
"datePublished": "2022-11-29",
"url": "https://questionsmedicales.fr/article/36445551",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12032-022-01883-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ivermectin induces cell cycle arrest and caspase-dependent apoptosis in human urothelial carcinoma cells.",
"datePublished": "2022-09-11",
"url": "https://questionsmedicales.fr/article/36185334",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7150/ijms.76623"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of Herniarin on Cell Viability, Cell Cycle, and Erk Protein Levels in Different Stages of Bladder Cancer Cells.",
"datePublished": "2024-02-14",
"url": "https://questionsmedicales.fr/article/38235946",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cbdv.202301645"
}
},
{
"@type": "ScholarlyArticle",
"name": "ML323, a USP1 inhibitor triggers cell cycle arrest, apoptosis and autophagy in esophageal squamous cell carcinoma cells.",
"datePublished": "2022-06-02",
"url": "https://questionsmedicales.fr/article/35654870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10495-022-01736-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Technologie, industrie et agriculture",
"item": "https://questionsmedicales.fr/mesh/D013676"
},
{
"@type": "ListItem",
"position": 3,
"name": "Produits manufacturés",
"item": "https://questionsmedicales.fr/mesh/D008420"
},
{
"@type": "ListItem",
"position": 4,
"name": "Dispositifs pour fumer",
"item": "https://questionsmedicales.fr/mesh/D000074602"
},
{
"@type": "ListItem",
"position": 5,
"name": "Produits du tabac",
"item": "https://questionsmedicales.fr/mesh/D062789"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Produits du tabac - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Produits du tabac",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Produits du tabac",
"description": "Comment diagnostiquer une dépendance au tabac ?\nQuels tests pour évaluer les effets du tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Produits du tabac",
"description": "Quels sont les symptômes d'une intoxication au tabac ?\nComment le tabac affecte-t-il la respiration ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Produits du tabac",
"description": "Comment prévenir le tabagisme chez les jeunes ?\nLes lois anti-tabac sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Produits du tabac",
"description": "Quels traitements existent pour arrêter de fumer ?\nLes thérapies comportementales sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Produits du tabac",
"description": "Quelles sont les complications du tabagisme ?\nLe tabac augmente-t-il le risque de cancer ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Produits du tabac",
"description": "Quels sont les facteurs de risque du tabagisme ?\nLe stress influence-t-il la consommation de tabac ?",
"url": "https://questionsmedicales.fr/mesh/D062789?mesh_terms=Cell+Cycle+Checkpoints&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dépendance au tabac ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des questionnaires d'auto-évaluation et l'observation des symptômes de sevrage."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer les effets du tabac ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fonction pulmonaire et des analyses de sang peuvent évaluer les effets du tabac."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une intoxication au tabac ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vertiges, maux de tête et palpitations cardiaques."
}
},
{
"@type": "Question",
"name": "Comment le tabac affecte-t-il la respiration ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabac provoque une toux chronique, un essoufflement et une diminution de la capacité pulmonaire."
}
},
{
"@type": "Question",
"name": "Comment prévenir le tabagisme chez les jeunes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation, les campagnes de sensibilisation et les politiques anti-tabac sont essentielles."
}
},
{
"@type": "Question",
"name": "Les lois anti-tabac sont-elles efficaces ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles réduisent la consommation de tabac et protègent les non-fumeurs de l'exposition."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour arrêter de fumer ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent les substituts nicotiniques, les médicaments et la thérapie comportementale."
}
},
{
"@type": "Question",
"name": "Les thérapies comportementales sont-elles efficaces ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles augmentent les chances d'arrêter de fumer en modifiant les comportements liés au tabagisme."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications du tabagisme ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent le cancer, les maladies cardiovasculaires et les maladies respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Le tabac augmente-t-il le risque de cancer ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabac est un facteur de risque majeur pour plusieurs types de cancer, notamment le poumon."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du tabagisme ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, l'environnement social, et l'exposition à des antécédents familiaux."
}
},
{
"@type": "Question",
"name": "Le stress influence-t-il la consommation de tabac ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut augmenter la consommation de tabac chez les individus dépendants."
}
}
]
}
]
}
Plant cells can undergo regulated cell death in response to exogenous factors (often in a stress context), but also as regular element of development (often regulated by phytohormones). The cellular a...
As a type of central nervous system tumor, meningioma usually compresses the nerve center due to its local expansion, further causing neurological deficits. However, there are limited therapeutic appr...
Bladder carcinoma is one of the most common malignancies worldwide, and >90% of all bladder cancers are classified as urothelial carcinomas (UC). Surgery, radiotherapy, chemotherapy, targeted therapy,...
This study examines the potential of herniarin from tarragon, as an agent with multifaceted effects on bladder cancer cells and investigates herniarin's impact on cell viability, migration, cell cycle...
Esophageal squamous cell carcinoma (ESCC) is a common digestive cancer with high mortality rate due to late diagnosis and drug resistance. It is important to identify new molecular target and develop ...
Targeting breast cancer stem cells with the CD44+/CD24- phenotype is critical for complete eradication of cancer cells due to its Self-renewal, differentiation, and therapeutic resistance ability. Que...
The human breast cancer cell line T47D was used for this experiment. T47D CSCs were isolated by magnetic bead sorting using the MACS system. The anticancer activity of Quercetin and Doxorubicin alone ...
We have shown that almost 1% of T47D cell populations are made up of CD44+/CD24- cells, which considered as cancer stem cells. Quercetin and Doxorubicin alone or in combination inhibited cell prolifer...
These outcomes suggested that CSCs are a minor population of cancer cells, which play a significant role in drug resistance by being quiescent, slow cycling and resistance to apoptosis. Furthermore, o...
Cells exposed to environmental stress arrest the cell cycle until they have adapted to their new environment. Cells adjust the length of the arrest for each unique stressor, but how they do this is no...
Therapy resistance in cancer is often driven by a subpopulation of cells that are temporarily arrested in a non-proliferative G0 state, which is difficult to capture and whose mutational drivers remai...
We develop methodology to robustly identify this state from transcriptomic signals and characterise its prevalence and genomic constraints in solid primary tumours. We show that G0 arrest preferential...
We propose a G0 arrest transcriptional signature that is linked with therapeutic resistance and can be used to further study and clinically track this state....
Age is a major risk factor for the acute and chronic complications of cancer chemotherapy. The current approach to the prevention of these complications is reactive and involves the reduction of the d...
molecular biology has revealed that different checkpoints control the proliferative cycle of normal and neoplastic cells. Two new drugs, Trilaciclib and ALRN-6924 may cause a temporary cell cycle arre...
In three randomized controlled phase II trials Trilaciclib proved effective in preventing neutropenia, thrombocytopenia and anemia in patients with non small cell lung cancer with non proficient RB1 g...
To prevent chromosome mis-segregation, a surveillance mechanism known as the spindle checkpoint delays the cell cycle if kinetochores are not attached to spindle microtubules, allowing the cell additi...